cagrisema phase 3 results 2025 obesity cagrilintide semaglutide Weight Loss Efficacy of and Cagrilintide is an amylin analogue
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination CagriSema Outperforms Semaglutide Alone Across Phase 3 REIMAGINE Trials HCPLive Coadministered Cagrilintide and Semaglutide, in Adults with Overweight or Obesity. June 22,, 2025. DOI: 10.1056 NEJMoa2502081, CagrilintideSemaglutide in Adults with, Overweight or Obesity and Type 2 What is cagrisema and how does it work for weight loss?
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

